Singapore deal boosts Pacific Edge


Wellington Pacific Edge shares have risen 6.5% after the cancer diagnostics firm signed its first commercial deal to supply its suite of Cxbladder tests in Singapore. The stock incre ased 2.5c to 41c after the Dunedin-based company said it reached a commercial agreement with a unit of Raffles Medical Group to use the bladder cancer […]

No posts to display